Febrile Neutropenia  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
PLIANT, NCT01619423 / 2012-001367-76: A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer

Completed
2
186
US, Europe, RoW
PledOx (2 µmol/kg), Calmangafodipir, PledOx (5 µmol/kg), PledOx (10 µmol/kg), Placebo (0,9% NaCl), Sodium chloride
Egetis Therapeutics, Pharma Consulting Group AB
Advanced Metastatic (Stage IV) Colorectal Cancer
03/16
12/16

Download Options